Filter
176
Text search:
counterfeit
drug
Featured
Recommendations
10
New Publications
56
Language
Document type
No document type
100
Studies & Reports
34
Guidelines
22
Manuals
7
Strategic & Response Plan
7
Situation Updates
3
Training Material
2
Fact sheets
1
Countries / Regions
Kenya
11
Uganda
10
Nigeria
7
Ethiopia
7
Ghana
7
Tanzania
6
Liberia
5
Cambodia
5
Sierra Leone
4
Zambia
4
Malawi
4
Botswana
4
Myanmar / Burma
4
Zimbabwe
3
South Africa
3
Bangladesh
3
Eswatini/ Swaziland
3
Cameroon
2
Philippines
2
Rwanda
2
Namibia
2
Ukraine
2
South–East Asia Region
2
Global
2
Burkina Faso
1
Congo, Democratic Republic of
1
Haiti
1
India
1
Somalia
1
Nepal
1
Pakistan
1
Thailand
1
China
1
Indonesia
1
Mozambique
1
Lesotho
1
Asia
1
Africa
1
Laos
1
Moldova
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
95
Public Health
8
Clinical Guidelines
8
Pharmacy & Technologies
6
Key Resources
2
Women & Child Health
1
Toolboxes
Pharmacy
30
AMR
28
Mental Health
6
TB
5
HIV
4
Global Health Education
4
Conflict
2
Rapid Response
2
Planetary Health
2
Disability
1
Specific Hazards
1
COVID-19
1
Caregiver
1
NCDs
1
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Accessed November, 2017
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
